
- /
- Supported exchanges
- / US
- / DGX.NYSE
Quest Diagnostics Incorporated (DGX NYSE) stock market data APIs
Quest Diagnostics Incorporated Financial Data Overview
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Quest Diagnostics Incorporated data using free add-ons & libraries
Get Quest Diagnostics Incorporated Fundamental Data
Quest Diagnostics Incorporated Fundamental data includes:
- Net Revenue: 10 158 M
- EBITDA: 1 975 M
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-21
- EPS/Forecast: 2.57
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quest Diagnostics Incorporated News

Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Quest Diagnostics (DGX), which belongs to ...


1 Mid-Cap Stock with Competitive Advantages and 2 to Brush Off
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe wit...

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Achieving those goals is made easier with the Zacks Style Scores, a unique se...

Quest Diagnostics launches test for Oropouche virus amid spread in Americas
SECAUCUS, N.J. - Quest Diagnostics (NYSE:DGX), a prominent player in the Healthcare Providers sector with annual revenue exceeding $10 billion, announced Tuesday the development of a new diagnostic la...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.